Investor Suvretta Capital Management, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Suvretta Capital Management, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-21 13G/A CMPX / Compass Therapeutics, Inc. 7,149,493 14,101,159
2025-08-13 13G/A PEPG / PepGen Inc. 1,660,932 300,000
2025-08-13 13G/A STRO / Sutro Biopharma, Inc. 5,778,188 6,488,324
2025-08-13 13G/A IMTX / Immatics N.V. 9,135,029 12,030,129
2025-08-13 13G CMPX / Compass Therapeutics, Inc. 7,149,493
2025-08-13 13G ERAS / Erasca, Inc. 12,315,004 14,502,004
2025-08-13 13G/A AURA / Aura Biosciences, Inc. 3,057,319 4,701,775
2025-08-13 13G/A ABEO / Abeona Therapeutics Inc. 3,685,503 2,676,000
2025-08-13 13G/A AVBP / ArriVent BioPharma, Inc. 2,040,365 3,412,788
2025-05-02 13G/A IMTX / Immatics N.V. 7,881,608 9,135,029
2025-05-02 13G/A ETNB / 89bio, Inc. 10,202,696 14,611,409
2025-05-02 13G/A FULC / Fulcrum Therapeutics, Inc. 3,404,612 5,067,394
2025-05-02 13G/A KURA / Kura Oncology, Inc. 5,198,189 7,561,000
2025-05-02 13G MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 4,284,806
2025-04-16 13G GLUE / Monte Rosa Therapeutics, Inc. 3,360,000
2025-04-11 13G AURA / Aura Biosciences, Inc. 3,057,319
2025-04-11 13G DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 15,176,015
2025-03-28 13D/A BNTC / Benitec Biopharma Inc. 14,329,937 15,623,659
2025-03-11 13G WHWK / Whitehawk Therapeutics, Inc. 4,727,510
2025-02-13 13G/A KURA / Kura Oncology, Inc. 7,472,343 5,198,189
2025-02-13 13G/A ERAS / Erasca, Inc. 13,768,039 12,315,004
2025-02-13 13G/A ETNB / 89bio, Inc. 7,991,644 10,202,696
2025-02-11 13G IMTX / Immatics N.V. 7,881,608
2025-02-11 13G MRNS / Marinus Pharmaceuticals, Inc. 5,463,641 3,022,612
2025-02-11 13G/A MRNS / Marinus Pharmaceuticals, Inc. 5,463,641 2,105,264
2025-02-07 13G PEPG / PepGen Inc. 1,660,932 1,660,932
2025-02-07 13G/A PEPG / PepGen Inc. 1,660,932 1,174,321
2025-01-06 13G FULC / Fulcrum Therapeutics, Inc. 1,182,791 3,404,612
2024-12-20 13G PVLA / Palvella Therapeutics, Inc. 714,463
2024-12-04 13G AVBP / ArriVent BioPharma, Inc. 2,040,365
2024-11-18 13D/A BNTC / Benitec Biopharma Inc. 8,829,053 14,329,937
2024-11-14 13G/A ZURA / Zura Bio Limited 2,850,000 4,860,939
2024-11-14 13G/A FULC / Fulcrum Therapeutics, Inc. 5,518,881 1,182,791
2024-11-14 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 36,854,190 0
2024-11-14 13G/A KALV / KalVista Pharmaceuticals, Inc. 2,684,005 4,328,904
2024-11-14 13G/A COGT / Cogent Biosciences, Inc. 5,481,034 0
2024-11-14 13G/A TERN / Terns Pharmaceuticals, Inc. 5,837,126 0
2024-10-22 13G/A PROK / ProKidney Corp. 4,725,348 13,198,766
2024-10-17 13G/A ETNB / 89bio, Inc. 4,888,434 7,991,644
2024-09-30 13D/A BNTC / Benitec Biopharma Inc. 1,700,850 8,829,053
2024-08-12 13G PEPG / PepGen Inc. 1,660,932
2024-05-28 13G ERAS / Erasca, Inc. 13,768,039
2024-05-13 13G ABEO / Abeona Therapeutics Inc. 3,685,503
2024-04-29 13D BNTC / Benitec Biopharma Inc. 262,843 1,700,850
2024-04-15 13G CTNM / Contineum Therapeutics, Inc. 1,720,000
2024-02-13 13G/A PROK / ProKidney Corp. 4,725,348
2024-02-13 13G/A KALV / KalVista Pharmaceuticals, Inc. 1,796,379 2,684,005
2024-02-13 13G/A SYRE / Spyre Therapeutics, Inc. 412,395
2024-02-13 13G/A KURA / Kura Oncology, Inc. 6,376,815 7,472,343
2024-02-13 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 36,822,190 36,854,190
2024-02-13 13G/A BNTC / Benitec Biopharma Inc. 262,843
2024-02-13 13G/A BHVN / Biohaven Ltd. 3,848,938 4,572,836
2024-02-13 13G/A ARQT / Arcutis Biotherapeutics, Inc. 9,592,212 9,534,837
2024-02-13 13G/A ETNB / 89bio, Inc. 4,808,374 4,888,434
2024-02-13 13G/A STRO / Sutro Biopharma, Inc. 5,565,099 5,778,188
2024-02-13 13G/A MRNS / Marinus Pharmaceuticals, Inc. 4,971,660 5,463,641
2024-02-13 13G/A FULC / Fulcrum Therapeutics, Inc. 4,274,803 5,518,881
2024-02-13 13G/A EYPT / EyePoint Pharmaceuticals, Inc. 3,411,210 4,774,389
2024-02-13 13G/A KZR / Kezar Life Sciences, Inc. 3,504,264 7,167,591
2024-02-13 13G/A ACLX / Arcellx, Inc. 2,350,333 2,435,974
2024-02-13 13G/A TERN / Terns Pharmaceuticals, Inc. 3,448,275 5,837,126
2024-02-05 13G COGT / Cogent Biosciences, Inc. 5,481,034
2023-10-30 13G ARQT / Arcutis Biotherapeutics, Inc. 9,592,212
2023-10-30 13G ETNB / 89bio, Inc. 4,808,374
2023-06-15 13G ZURA / Zura Bio Limited 2,850,000
2023-04-24 13G IFRX / InflaRx N.V. 2,146,240 5,733,910
2023-04-18 13G/A BLT / BENITEC BIOPHARMA INC 6,328,698 3,020,214
2023-03-10 13G KALV / KalVista Pharmaceuticals, Inc. 1,072,302 1,796,379
2023-02-13 13G/A PROK / ProKidney Corp. 6,280,175
2023-02-13 13G/A IRON / Disc Medicine, Inc. 0
2023-02-13 13G/A BHVN / Biohaven Ltd. 3,840,338 3,848,938
2023-02-13 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 45,710,335 36,822,190
2023-02-13 13G/A KURA / Kura Oncology, Inc. 3,572,419 6,376,815
2023-02-13 13G/A BOLT / Bolt Biotherapeutics, Inc. 2,230,250 0
2023-02-13 13G/A BLT / BENITEC BIOPHARMA INC 769,000 6,328,698
2023-02-13 13G/A IFRX / InflaRx N.V. 6,285,000 2,146,240
2023-02-13 13G/A STRO / Sutro Biopharma, Inc. 2,473,795 5,565,099
2023-02-13 13G/A KALV / KalVista Pharmaceuticals, Inc. 1,746,300 1,072,302
2023-02-13 13G/A CMRX / Chimerix, Inc. 4,948,000 0
2023-02-13 13G/A CANO / Cano Health, Inc. 10,547,556 0
2023-02-13 13G/A ACLX / Arcellx, Inc. 2,470,559 2,350,333
2023-02-13 13G/A KZR / Kezar Life Sciences, Inc. 3,141,800 3,504,264
2023-02-13 13G/A EYPT / EyePoint Pharmaceuticals, Inc. 3,482,109 3,411,210
2023-02-13 13G/A FULC / Fulcrum Therapeutics, Inc. 2,375,571 4,274,803
2023-02-13 13G/A MRNS / Marinus Pharmaceuticals, Inc. 2,638,775 4,971,660
2023-02-13 13G/A SIOX / Sio Gene Therapies Inc. 5,914,000 0
2023-02-13 13G/A OTIC / Otonomy Inc 5,993,689 0
2023-02-13 13G/A SLDB / Solid Biosciences Inc. 0
2023-02-13 13G/A AGLE / Aeglea BioTherapeutics Inc 2,571,000 6,376,373
2023-01-03 13G TERN / Terns Pharmaceuticals, Inc. 3,448,275
2022-11-02 13G BHVN / Biohaven Ltd. 3,840,338
2022-07-22 13G PROK / ProKidney Corp. 6,269,300 6,269,300
2022-06-27 13G ACLX / Arcellx, Inc. 2,470,559
2022-06-13 13G KZR / Kezar Life Sciences, Inc. 3,141,800
2022-05-02 13G CMRX / Chimerix, Inc. 4,948,000
2022-02-14 13G/A MTTR / Matterport, Inc. 0 0
2022-02-14 13G/A ACHR / Archer Aviation Inc. 2,600,000 0
2022-02-14 13G/A KPLT / Katapult Holdings, Inc. 0 0
2022-02-11 13G/A TPGY / TPG Pace Beneficial Finance Corp - Class A 2,075,000 0
2022-02-11 13G/A SLNO / Soleno Therapeutics, Inc. 5,758,200 0
2022-02-11 13G/A MRNS / Marinus Pharmaceuticals, Inc. 2,052,358 2,638,775
2022-02-11 13G/A OTIC / Otonomy Inc 6,018,878 5,993,689
2022-02-11 13G/A PNT / POINT Biopharma Global Inc. 2,672,863
2022-02-11 13G/A SLDB / Solid Biosciences Inc. 5,974,193 6,287,193
2022-02-11 13G/A FTCV / FinTech Acquisition Corp V - Class A 1,901,890 0
2022-02-11 13G/A US0846561076 / Berkshire Grey, Inc. 0
2022-02-11 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 31,827,500 45,710,335
2022-02-11 13G/A KALV / KalVista Pharmaceuticals, Inc. 1,296,452 1,746,300
2022-02-11 13G/A SIOX / Sio Gene Therapies Inc. 5,489,000 5,914,000
2022-02-11 13G/A KURA / Kura Oncology, Inc. 3,503,419 3,572,419
2022-02-11 13G/A STRO / Sutro Biopharma, Inc. 2,408,395 2,473,795
2022-02-11 13G/A GMTX / Gemini Therapeutics Inc 2,232,843 2,372,267
2022-02-11 13G/A CANO / Cano Health, Inc. 8,708,864 10,547,556
2022-02-11 13G/A EYPT / EyePoint Pharmaceuticals, Inc. 1,595,164 3,482,109
2022-02-11 13G/A FULC / Fulcrum Therapeutics, Inc. 1,796,918 2,375,571
2021-12-16 13G AGLE / Aeglea BioTherapeutics Inc 2,571,000
2021-12-10 13G STRO / Sutro Biopharma, Inc. 2,408,395
2021-12-09 13G KURA / Kura Oncology, Inc. 3,503,419
2021-11-29 13G BOLT / Bolt Biotherapeutics, Inc. 2,230,250
2021-10-15 13G GMTX / Gemini Therapeutics Inc 899,457 2,232,843
2021-09-17 13G KALV / KalVista Pharmaceuticals, Inc. 1,296,452
2021-08-20 13G MRNS / Marinus Pharmaceuticals, Inc. 2,052,358
2021-08-10 13G FULC / Fulcrum Therapeutics, Inc. 1,796,918
2021-07-30 13G CANO / Cano Health, Inc. 8,708,864
2021-07-26 13G EYPT / EyePoint Pharmaceuticals, Inc. 1,595,164
2021-05-07 13G BNTC / Benitec Biopharma Inc. 769,000
2021-04-23 13G FTCV / FinTech Acquisition Corp V - Class A 1,901,890
2021-04-22 13G OTIC / Otonomy Inc 6,018,878
2021-04-02 13G / Therapeutics Acquisition Corp. Class A 1,095,400
2021-03-29 13G SLDB / Solid Biosciences Inc. 5,974,193
2021-03-08 13G IFRX / InflaRx N.V. 6,285,000
2021-03-01 13G US76156P1066 / RAAC Series 2004-SP1 Trust 2,450,000
2021-02-26 13G SIOX / Sio Gene Therapies Inc. 5,489,000
2021-02-19 13G MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 31,827,500
2021-02-16 13G US38286R1059 / GORES HOLDINGS VI INC 2,750,000
2021-02-16 13G/A / Jaws Acquisition Corp 3,500,000 4,000,000
2021-02-16 13G/A OPEN / Opendoor Technologies Inc. 4,100,000 8,265,465
2021-02-16 13G ACHR / Archer Aviation Inc. 2,600,000
2021-02-16 13G/A / FinServ Acquisition Corp 2,000,000 2,100,000
2021-02-16 13G/A TPGY / TPG Pace Beneficial Finance Corp - Class A 2,025,000 2,075,000
2021-02-12 13G US436313FW54 / Holicity Inc. Class A 711,750
2020-12-21 13G / FinServ Acquisition Corp 2,000,000
2020-12-18 13G TPGY / TPG Pace Beneficial Finance Corp - Class A 2,025,000
2020-11-13 13G / Jaws Acquisition Corp 3,500,000
2020-11-09 13G SLNO / Soleno Therapeutics, Inc. 5,758,200
2020-10-26 13G GMTX / Gemini Therapeutics Inc 899,457
2020-10-14 13G RADI / Radius Global Infrastructure Inc - Class A 2,837,033
2020-09-22 13G OPEN / Opendoor Technologies Inc. 4,100,000
2020-02-14 13G/A SPCE / Virgin Galactic Holdings, Inc. 6,671,693
2019-09-23 13G IPOA.U / Social Capital Hedosophia 4,507,400